Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

Illumina is one of Mainboard-listed Venture Corporation’s major customers. Illumina’s shares have fallen some 26.4% over the ...

Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of ...

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

The deal has taken a heavy toll on Illumina, whose business is otherwise lucrative thanks to its ubiquitous DNA sequencing machines. Grail’s greater-than-expected expenditures and delays in ...

Highly technical and precise machines called DNA sequencers are used for genome sequencing, and there are two main methods ...

“Without this machine, we can't do anything at the ... now the vice president and general manager of Illumina's DNA sequencing business unit following the acquisition of Solexa Ltd. by Illumina.

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

The "most promising areas" are integrated device manufacturers (IDMs) and high-end outsourced assembly and test (OSAT) ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

With low machine costs, short sequencing time and reasonable amount of throughput, desktop sequencers such as Ion Torrent PGM, and its second-generation technology competitors, Illumina's MiSeq ...